NKGN

NKGen Biotech, Inc. Common Stock
NKGN

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NKGN was delisted on the 4th of March, 2025.

Back to rankings

25 hedge funds and large institutions have $65.3M invested in NKGen Biotech, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
25
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$4.64M
2
+$2.6M
3
+$1.09M
4
Walleye Capital
Walleye Capital
New York
+$207K
5
VF
Virtu Financial
New York
+$127K

Top Sellers

1
-$13.7M
2
-$8.94M
3
-$8.17M
4
CIM
Cowen Investment Management
New York
-$7.6M
5
CSS
Cubist Systematic Strategies
Connecticut
-$5.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
27
–
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3